Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
West Indian med. j ; West Indian med. j;49(Supp 2): 36, Apr. 2000.
Artículo en Inglés | MedCarib | ID: med-955

RESUMEN

OBJECTIVE: Helicobacter pylori eradication is essential in patients with peptic ulcer who are infected with the organism. The rate of eradication is related to the level of antimicrobial resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in H pylori in this community. DESIGN AND METHODS: Gastric biopsies from all patients undergoing upper gastrointestinal endoscopy were cultured. Isolation was done on Thayer-Martin medium under microaerophilic conditions and isolates were sub-cultured on chocolate agar. MICs were determined using the E-test. RESULTS: 64 isolates were available for testing. Metronidazole resistance (MIC > 8mg/l) was observed in 39 percent (25/64), clarithromycin resistance (MIC > 2mg/l) in 4.7 percent (3/64), amoxycillin resistance (MIC > 8mg/l) in 4.7 percent (3/64) and tetracycline resistance (MIC > 4mg/l) in 3.1 percent (2/64). CONCLUSIONS: The high level of metronidazole resistance precludes the use of this antibiotic as first line therapy for H pylori in Barbados. It is recommended that a proton pump inhibitor, amoxycillin and clarithromycin be the combination of choice for eradication of H pylori in patients in Barbados.(Au)


Asunto(s)
Humanos , Helicobacter pylori/inmunología , Farmacorresistencia Microbiana/inmunología , Úlcera Péptica/prevención & control , Endoscopía Gastrointestinal/instrumentación , Metronidazol/aislamiento & purificación , Bombas de Protones/agonistas , Claritromicina/uso terapéutico , Barbados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA